Heights Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 96

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.44M

  • Investors
  • 22

Heights General Information

Description

Producer of smart supplements intended to elevate and extend cognitive performance by nourishing the brain. The company's supplements focus on giving the brain the fuel it needs to improve its health performance and mental well-being, enabling customers to get the nourishment they require according to neuroscience and optimize human potential.

Contact Information

Website
www.heights.com
Formerly Known As
Grabble, Mobula
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 27 Old Gloucester Street
  • London WC1N 3AX
  • England, United Kingdom
Primary Industry
Pharmaceuticals
Other Industries
Other Consumer Non-Durables
Vertical(s)
LOHAS & Wellness, E-Commerce
Corporate Office
  • 27 Old Gloucester Street
  • London WC1N 3AX
  • England, United Kingdom

Heights Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Heights Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC 09-Nov-2026 $5.44M Completed Generating Revenue
14. Debt - General 01-Oct-2026 Completed Generating Revenue
13. Equity Crowdfunding 21-Oct-2024 Completed Generating Revenue
12. Secondary Transaction - Private 01-Jan-2023 Completed Generating Revenue
11. Later Stage VC 01-Oct-2022 Completed Generating Revenue
10. Later Stage VC 20-Dec-2021 Completed Generating Revenue
9. Seed Round 28-Jan-2021 Completed Generating Revenue
8. Grant 01-Oct-2020 Completed Generating Revenue
7. Seed Round 13-Feb-2018 $2.28M $7.45M Completed Generating Revenue
6. Accelerator/Incubator 05-Dec-2017 $5.17M Completed Generating Revenue
To view Heights’s complete valuation and funding history, request access »

Heights Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 546,376 $0.000133 $0.68 $0.68 1x $0.68 2.25%
Ordinary 2,950,951 $0.000133 $0.61 $0.61 1x $0.61 12.15%
To view Heights’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Heights Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Producer of smart supplements intended to elevate and extend cognitive performance by nourishing the brain. The company'
Pharmaceuticals
London, United Kingdom
96 As of 2026

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Heights Competitors (1)

One of Heights’s competitors is Vitabiotics, a Private Equity-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vitabiotics Private Equity-Backed London, United Kingdom
You’re viewing 1 of 1 competitors. Get the full list »

Heights Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Heights Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kalytix Ventures Venture Capital Minority
TrueSight Ventures Venture Capital Minority
ForGood Global Impact Investing Minority
Angel (individual) Minority
Spacestation (UK) Angel Group Minority
You’re viewing 5 of 22 investors. Get the full list »

Ready to get started?

Request a free trial

Heights FAQs

  • When was Heights founded?

    Heights was founded in 2013.

  • Where is Heights headquartered?

    Heights is headquartered in London, United Kingdom.

  • What is the size of Heights?

    Heights has 96 total employees.

  • What industry is Heights in?

    Heights’s primary industry is Pharmaceuticals.

  • Is Heights a private or public company?

    Heights is a Private company.

  • What is the current valuation of Heights?

    The current valuation of Heights is .

  • What is Heights’s current revenue?

    The current revenue for Heights is .

  • How much funding has Heights raised over time?

    Heights has raised $30.3M.

  • Who are Heights’s investors?

    Kalytix Ventures, TrueSight Ventures, ForGood Global, , and Spacestation (UK) are 5 of 22 investors who have invested in Heights.

  • Who are Heights’s competitors?

    Vitabiotics is a competitor of Heights.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process